In a pharmaceutical plant, hazardous waste is present in production itself: spent solvents, expired raw materials, chemical-contaminated packaging and sludge from wastewater treatment. Misclassification or handover to an unqualified treater exposes the company to administrative fines and possible suspension of operations. This article clarifies the waste generator’s legal duties from classification, collection and storage through handover for treatment under current regulations.
1. Identifying hazardous waste in drug manufacturing
Unlike healthcare facilities where infectious waste dominates, drug plants mainly generate non-infectious hazardous waste: used organic solvents, expired chemicals, rejected off-spec raw materials, packaging with chemical residues and sludge contaminated with heavy metals or organic compounds. Under the Law on Environmental Protection 72/2020/QH14 and Decree 08/2022/ND-CP, waste generators must identify and classify waste at the source. Detailed classification principles for hazardous medical waste are guided by Circular 20/2021/TT-BYT — although its scope covers healthcare facility premises, drug companies may refer to these principles when building internal procedures.
2. Collection, storage and management records
Hazardous waste must be collected separately by type, kept in suitable packaging and storage equipment, and stored in a dedicated area with warning signs plus leak, fire and explosion prevention measures. Decree 08/2022/ND-CP requires generators to maintain records tracking quantities, categories and every handover movement of waste. Inspections show many companies are fined not for illegal dumping but for lacking records proving the waste trail — failure to prove proper treatment is treated as a violation in itself. Building disciplined internal logs is therefore as important as choosing the right treater.
3. Handover for treatment and the environmental license
Generators may not destroy hazardous waste themselves using unlicensed methods; waste must be handed to a licensed hazardous waste treater under contract with complete handover documents. At project level, a drug plant must hold an environmental license under the Law on Environmental Protection 72/2020, with waste management as a mandatory dossier component. Companies should include waste treatment clauses in contracts with treaters from the outset, clearly allocating responsibility for leaks, fires or explosions during transport.
Conclusion
Hazardous waste management in drug production is a closed chain of duties: identification and source classification, proper collection and storage, record keeping, and handover only to licensed treaters. The crux lies not in treatment technology but in record discipline and the generator’s diligence. During inspections, companies prove compliance with documents, not explanations — a lesson many manufacturers learn only after the first fine.
Frequently asked questions
1. Is spent solvent from drug production hazardous waste?
Yes; used organic solvents fall under hazardous waste; they must be classified at source, stored separately and handed to a licensed treater.
2. Does Circular 20/2021/TT-BYT apply to drug plants?
It governs medical waste management within healthcare facility premises. Drug plants follow the hazardous waste regime under the Environmental Protection Law and Decree 08/2022, but may refer to the circular’s classification principles for internal procedures.
3. Can a plant burn hazardous waste on its own premises?
No, unless it holds a hazardous waste treatment license with approved technology; unauthorized destruction is a violation subject to heavy fines.
4. What do hazardous waste management records include?
Logs of quantities and categories; contracts and handover documents with the treater; periodic reports as required. Missing records can draw fines even when waste was properly treated.
5. What should companies check when hiring a treater?
Verify the hazardous waste treatment license is valid and covers the relevant scope; sign a contract clearly allocating each party’s responsibilities; keep complete handover documents for every shipment.
This article has been quality-reviewed by the FLAW AI Legal Council.
